Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002231312 | SCV000631552 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2023-12-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001653891 | SCV001861674 | likely benign | not provided | 2021-06-15 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279341 | SCV002565788 | uncertain significance | Ehlers-Danlos syndrome | 2019-12-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002367798 | SCV002664642 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-09-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003488666 | SCV004241192 | benign | not specified | 2023-12-17 | criteria provided, single submitter | clinical testing |